Theolytics
Oxford
About Theolytics
Theolytics is a clinical stage biotechnology company harnessing viruses to combat disease. A step-change in the adenoviral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing an internal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $73.5M
- Last round: Grant (Mar 2026)
- Website: theolytics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/theolytics-7315 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.